Miconia myriantha
Miconia myriantha · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Miconia myriantha is a distinctive botanical species known for its unique morphological characteristics and potential medicinal value. Recent phytochemical investigations have focused on the plant's leaves to uncover their bioactive potential. Through the process of creating an ethanol extract, researchers have been able to isolate specific secondary metabolites from the foliage. One significant chemical compound identified within these preparations is gallic acid, which is recognized for its antioxidant properties. Understanding the concentration of such compounds is essential for exploring the therapeutic applications of this plant.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Melastomataceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Taxonomy
Miconia myriantha is a fascinating biological specimen that belongs to the vast kingdom Plantae. Within this botanical realm, the plant is classified under the class Equisetopsida. It further belongs to the order Myrtales, showcasing its specific evolutionary lineage. This species is a distinguished member of the genus Miconia. Finally, it is categorized under the family Melastomataceae, highlighting its unique structural characteristics.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Melastomataceae |
| Genus | Miconia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Miconia myriantha is a versatile plant species with a widespread presence across much of the tropical landscape. Its distribution stretches from the lush regions of Brazil through the diverse ecosystems of Central America, including Belize. The plant is also extensively found throughout Northern South America, establishing strong roots in territories such as French Guiana. Furthermore, it thrives within the unique environments of Guyana and Suriname. This broad geographic range highlights the species' ability to adapt to various South and Central American habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Miconia myriantha is a self-supporting plant that takes the form of a tree. It typically reaches a maximum height of 9 meters as it matures. This growth habit allows it to establish a sturdy presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Miconia myriantha has been identified as a significant source of various bioactive phenolic compounds. Through the assay-guided fractionation of its twig and leaf extracts, researchers have successfully isolated several key constituents. Specifically, the plant was found to contain both gallic acid and ellagic acid. These chemical components contribute to the complex profile of the species, which is being studied for its medicinal potential. Notably, the presence of ellagic acid has demonstrated inhibitory effects against certain aspartic proteases.
Conditions
Miconia myriantha contains specific phenolic compounds that effectively treat Candida albicans secreted aspartic proteases. Through assay-guided fractionation of its twigs and leaves, researchers identified several key bioactive molecules. Notably, compound 1 and ellagic acid demonstrated significant inhibitory effects against these fungal proteases. These compounds achieved potent results with IC50 values of 8.4 and 10.5 microM, respectively. This chemical interaction highlights the plant's potential for neutralizing specific enzymatic activities of the pathogen.
Preparations
Miconia myriantha is prepared as an ethanol extract derived from its twigs and leaves. This specific preparation allows for the assay-guided fractionation of the plant's components. Through this process, several key phenolic compounds are isolated from the extract. These extracted substances, such as mattucinol derivatives and ellagic acid, are central to the study's chemical analysis. Ultimately, the ethanol extract serves as the essential source for identifying compounds that inhibit Candida aspartic proteases.
Parts used
Miconia myriantha serves as a valuable source of bioactive chemical constituents for pharmacological study. Researchers have specifically focused on the leaves and twigs of this plant to conduct assay-guided fractionation of ethanol extracts. This process successfully yielded several unique phenolic compounds, including new derivatives of mattucinol. Notably, these leaf-derived compounds demonstrated significant inhibitory effects against Candida albicans secreted aspartic proteases. Such findings highlight the medicinal potential found within the specific plant parts of Miconia myriantha.